DrugCendR Inc. — Form D

DrugCendR Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-22. $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-02-22
• Form: D
• Accession: 0001729308-18-000002
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $1.0M
• Minimum investment: $30K
• Investors: 5
• Date of first sale: 2017-03-23
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-306253

Issuer

• Name: DrugCendR Inc.
• CIK: 0001729308
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Incorporated: 2016
• Address: 10901 N TORREY PINES RD, LA JOLLA, CA, 92037
• Phone: 8586463101

Officers, directors & promoters (1)

Other filings by this issuer (1)

More

• CIK 1729308 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search